戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ng formulations containing papain, ficin, or bromelain.
2 rongly correlated with those of SA-CAP-1 and bromelain.
3 nded to 2% to 3% of the reactivity seen with bromelain.
4 f zingibain and had no significant effect on bromelain.
5 tin, AcCYS1, inhibited (>95%) stem and fruit bromelain.
6 erase to proteolysis by papain, trypsin, and bromelain.
7 ained by varying the time of hydrolysis with bromelain.
8                     Of 52 CCD-positive sera (bromelain, 1.01-59.6 kilounits of antigen per liter [kUA
9                                              Bromelain, a mixture of cysteine proteases from pineappl
10                                 We show that bromelain, a mixture of cysteine proteases from pineappl
11 vestigate the possible therapeutic effect of bromelain, a proteolytic extract obtained from pineapple
12 he activity of four plant proteases (papain, bromelain, actinidin and zingibain) and three microbial
13 equence homology with other members (papain, bromelain, actinidin, protease omega, etc.) of this fami
14                                              Bromelain also blocked signaling induced by carbachol an
15                                Surprisingly, bromelain also did not block serovar Typhimurium-induced
16                                              Bromelain also inhibited PMA-induced IL-2, IFN-gamma, an
17                                              Bromelain also prevented secretory changes caused by pro
18 ates were produced using two proteases (stem Bromelain and Endocut-02) and two collagen-rich poultry
19 all than hydrolysates generated with papain, bromelain and FP400.
20  test (BAT) with both venoms as well as with bromelain and horseradish peroxidase (HRP) or recombinan
21 ffective in overall allergenicity reduction; bromelain and Neutrase were the least effective in reduc
22  mice exposed to cysteine proteases, such as bromelain and papain, as a model for allergens.
23  0.8-3.2mM inhibited the activity of papain, bromelain and zingibain, iso-AA acted as an inhibitor of
24 Protease preparations from plant (papain and bromelain) and fungal (FP400 and FPII) sources were used
25 protease preparations from plant (papain and bromelain) and fungal (FP400 and FPII) sources.
26  and a BAT (Flow2 CAST) with venom extracts, bromelain, and HRP was performed.
27 teine proteases (clan CA, family C1) papain, bromelain, and human cathepsins L, V, K, S, F, B, and fi
28 ctinidin (0.8%/min) when compared to papain, bromelain, and one commercial enzyme (on average 0.4%/mi
29  umami sensor outputs were characteristic of bromelain- and Flavourzyme-produced hydrolysates, compar
30         Restructured pork steak treated with bromelain at 0.05 and 0.1% (w/w) was hydrolysed at 50 C
31 3, 1% ficin-based whitening; and group 4, 1% bromelain-based whitening.
32 on, Brix 3000, bromelain-contained gel (F1), bromelain-chloramine-T (F2), and bromelain-chlorhexidine
33                                          The bromelain-chloramine-T gel (F2) produced the smoothest s
34 d gel (F1), bromelain-chloramine-T (F2), and bromelain-chlorhexidine gel (F3).
35 ix evaluated different enzymatic treatments (bromelain, chondroitinase ABC, papain, and trypsin).
36          In this study, purified HA trimers (bromelain-cleaved HA [BHA]) are used to examine the prop
37 oteins degradation levels were recorded with Bromelain compared to Flavourzyme and Alcalase, and upon
38 nstrated that the systemic administration of bromelain conjugated C4BP-HA (C4BP-HA-Bro) potentiates t
39 f retained dentin after applying three novel bromelain-contained chemomechanical caries removal (CMCR
40                                          The bromelain-contained formulations can be considered a new
41 nd excavation, rotary excavation, Brix 3000, bromelain-contained gel (F1), bromelain-chloramine-T (F2
42                                              Bromelain did not act on ERK-2 directly, as it also inhi
43  solvents, hot alkali, or proteases (papain, bromelain) diminished the adsorption rates of the biosor
44                        Our results show that bromelain dose dependently blocks serovar Typhimurium-in
45 e inhibitory potency of AcCYS1 against fruit bromelain during fruit ripening to increase tissue prote
46            Enzymatic tenderisation including bromelain enhances underused cuts of meat in emerged res
47 n after agar extraction was hydrolysed using bromelain (enzyme activity=119,325 U/g) at 0-20% (w/w) f
48 t functions, including plant enzymes papain, bromelain, ficin, and mammalian lysosomal cathepsins B a
49                                              Bromelain, ficin-based, and carbamide peroxide bleaching
50 s produced by different proteases (Alcalase, bromelain, Flavourzyme, Protamex, Protease A"Amano"2, Pr
51            The cooking losses of 0.05% (w/w) bromelain for 0, 3 and 6 min were lower than 0.1% (w/w)
52 tions for the production of eb-SWPH were 10% bromelain for 3h, which resulted in a 38.15% yield and a
53 potential for effective and safe delivery of bromelain for improved intratumoral delivery of therapeu
54 s of restructured pork steak hydrolysed with bromelain for masticatory dysfunction people were evalua
55 tions from plant and fungal sources (papain, bromelain, FP400 and FPII) were used to hydrolyse plasma
56 city (ORAC) compared to those generated with bromelain, FP400 and FPII.
57 interactions that was prepared from purified bromelain glycopeptides and human serum albumin.
58 h NTT was required to inhibit fruit and stem bromelain (>95%), whereas its removal decreased inhibiti
59 mes, such as collagenase, hyaluronidase, and bromelain, have been used to facilitate the accumulation
60                sIgE antibodies to MUXF3 CCD, bromelain, HRP, rApi m 1, and rVes v 5 were determined,
61                                     BAT with bromelain/HRP showed a sensitivity of 50%/81% and a spec
62                              Autolysates and bromelain hydrolysates from aerobic yeast had low levels
63 gE directed against CCDs was investigated by bromelain IgE inhibition and concanavalin A binding assa
64                                      Despite bromelain inhibition of serovar Typhimurium-induced MAP
65 eep containing a pair of tandemly duplicated bromelain inhibitors.
66         Here, we report targeted delivery of bromelain into tumor tissues through its covalent attach
67                       Data also confirm that bromelain is a novel inhibitor of MAP kinase signaling p
68                    The results indicate that bromelain is a novel inhibitor of T cell signal transduc
69 AA) than simple autolysis or hydrolysis with bromelain, most significantly when applied to aerobic ye
70 ly poor inhibitors of the cysteine protease, bromelain, of pineapple (Ananas comosus).
71     In this study, we examined the effect of bromelain on Salmonella enterica serovar Typhimurium inf
72            Partial hydrolysis with alcalase, bromelain, or papain increased the solubility of OPI but
73              Tooth bleaching gels containing bromelain, papain, or ficin have substantial clinical po
74                                The effect of bromelain pretreatment on short-circuit responses to Esc
75                                              Bromelain prevents intestinal fluid secretion mediated b
76 piglets challenged with this infection after bromelain prophylaxis.
77  Binding correlated with antibody binding to bromelain (r = 0.61) and to all blank ImmunoCAPs (r > 0.
78 g to SA-CAP-1 correlated with IgE binding to bromelain (r = 0.68) and was completely abolished by ser
79 re treated by Alcalase, papain, Neutrase and bromelain, respectively.
80 ss of 0.05% (w/w) had higher than 0.1% (w/w) bromelain samples.
81 or 0, 3 and 6 min were lower than 0.1% (w/w) bromelain samples.
82                         In this regard, stem bromelain (SBM), a pharmacologically active member of th
83                                 An enzymatic bromelain seaweed protein hydrolysate (eb-SWPH) was char
84                                              Bromelain-treated samples at higher concentrations showe
85 agen contents were the highest in 0.1% (w/w) bromelain-treated samples for 12 min (P < 0.05).
86               This phase was obliterated for bromelain-treated virions with the ectodomains removed.
87 ed by readily available proteases (elastase, bromelain, trypsin, and proteinase K).
88 rvirens pollen extracts is mainly related to bromelain-type epitopes of a newly identified cypress PG
89                                              Bromelain was 62% effective in preventing heat-labile en
90                   The inhibitory activity of bromelain was dependent on its proteolytic activity, as
91                              The efficacy of bromelain was not caused by reduced tissue viability res
92                            Papain, ficin and bromelain were selected out of eight food-grade enzymes
93         The benefit of the proteolytic agent bromelain, which degrades enterocyte receptors for enter
94 (AC) restructured pork steak hydrolyzed with bromelain with addition of LA gellan, LM pectin and kapp